Showing results (81-90 of 116) with videos related to
Sort By:
Pageof 12
Frontiers in Immunology|September 29, 2025
Impact of Fusobacterium nucleatum on immune cell interactions and gene expression in colorectal cancer: a retrospective cohort studyRonald Heregger, Florian Huemer, Richard Greil, et al.Cancer Immunology Research|August 8, 2020
CD39 Identifies the CD4+ Tumor-Specific T-cell Population in Human CancerKim E Kortekaas, Saskia J Santegoets, Gregor Sturm, et al.Nature Communications|April 20, 2018
Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockadeVictoria Klepsch, Natascha Hermann-Kleiter, Patricia Do-Dinh, et al.The Journal of Biological Chemistry|October 25, 2013
NAT8L (N-acetyltransferase 8-like) accelerates lipid turnover and increases energy expenditure in brown adipocytesAriane R Pessentheiner, Helmut J Pelzmann, Evelyn Walenta, et al.Oncoimmunology|December 21, 2023
Driver mutations in GNAQ and GNA11 genes as potential targets for precision immunotherapy in uveal melanoma patientsSandra García-Mulero, Roberto Fornelino, Marco Punta, et al.Cellular and Molecular Life Sciences : CMLS|June 17, 2010
Reconstruction of gene association network reveals a transmembrane protein required for adipogenesis and targeted by PPARγJuliane G Bogner-Strauss, Andreas Prokesch, Fatima Sanchez-Cabo, et al.Nature Immunology|August 5, 2020
Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagyTakahiro Yamazaki, Alexander Kirchmair, Ai Sato, et al.Cell Reports|October 5, 2021
CHD1 controls H3.3 incorporation in adult brain chromatin to maintain metabolic homeostasis and normal lifespanInes Schoberleitner, Ingo Bauer, Anming Huang, et al.International Journal of Cancer|October 30, 2021
NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell divisionLinda Borst, Marjolein Sluijter, Gregor Sturm, et al.Cell Death and Differentiation|August 28, 2021
Stress-induced inflammation evoked by immunogenic cell death is blunted by the IRE1α kinase inhibitor KIRA6 through HSP60 targetingNicole Rufo, Dimitris Korovesis, Sofie Van Eygen, et al.Pageof 12